US-based Penumbra has completed enrolment for the THUNDER Investigational Device Exemption study of its advanced thrombectomy technology for acute ischemic stroke treatment. This study will ...

Pathophysiology of Ischemic Stroke Ischemic stroke is caused by a reduction of blood flow to the brain, which may lead to cell death by a variety of mechanisms including excitotoxicity, ionic ...

In a mouse model of acute ischemic stroke, researchers showed that inhibiting the aggregation of GAPDH, either genetically or ...

ALAMEDA, Calif., Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for ...

If anything, the peripheral market is even less penetrated than the present-day addressable ischemic stroke market, and Penumbra’s share of the available market is only around 10% to 20%.

Know Where to Go if Stroke Strikes: Penumbra, Inc. Launches QuEST2StopStroke.com <0> Penumbra Media Relations:Rachael Kopeck, 510-748-3200orThe Ruth GroupKimberly Muscara, 646-536-7011 </0> ...

Penumbra’s most advanced thrombectomy device, the ACE™68 Reperfusion Catheter, part of the fully integrated Penumbra System®, was launched at the SNIS ...

Penumbra, Inc. announced U.S. commercial availability of the Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology at SNIS.

Figure 11. Prevalence of penumbra in acute ischemic stroke patients. The study included 109 consecutive patients who presented to the emergency department with symptoms suggesting recent stroke ...